Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Bactiguard Holding AB's annualizedNet Income for the quarter that ended in Mar. 2026 was kr-22.2 Mil. Bactiguard Holding AB's average total tangible assets for the quarter that ended in Mar. 2026 was kr243.2 Mil. Therefore, Bactiguard Holding AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -9.15%.
The historical rank and industry rank for Bactiguard Holding AB's Return-on-Tangible-Asset or its related term are showing as below:
CHIX:BACTBs'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -38.62 Med: -12.4 Max: 10.5
Current: -3.54
During the past 13 years, Bactiguard Holding AB's highest Return-on-Tangible-Asset was 10.50%. The lowest was -38.62%. And the median was -12.40%.
CHIX:BACTBs's Return-on-Tangible-Asset is ranked worse than 58.23% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.57
vs CHIX:BACTBs: -3.54
Bactiguard Holding AB (CHIX:BACTBs) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Bactiguard Holding AB Return-on-Tangible-Asset Related Terms
Bactiguard Holding AB Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB Return-on-Tangible-Asset Chart
CHIX:BACTBS vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Bactiguard Holding AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -9.15% mean?
Bactiguard Holding AB (CHIX:BACTBS) has a Return-on-Tangible-Asset of -9.15% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Bactiguard Holding AB and its competitors. According to the industry distribution chart, Bactiguard Holding AB ranks #499 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 58.2%.
Is Bactiguard Holding AB's Return-on-Tangible-Asset too high?
Bactiguard Holding AB's current Return-on-Tangible-Asset is -9.15%. Based on the distribution chart, Bactiguard Holding AB ranks #499 out of 857 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bactiguard Holding AB has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #499 out of 857 companies for Return-on-Tangible-Asset. This places Bactiguard Holding AB in the lower half of its industry. The industry median Return-on-Tangible-Asset is 0.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.57, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Bactiguard Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current Return-on-Tangible-Asset is -9.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Return-on-Tangible-Asset of -9.15%. The stock's GF Value™ is kr266.73, compared to a current price of kr128.60 — trading 51.8% below its estimated fair value. The current Return-on-Tangible-Asset is -9.15%. Bactiguard Holding AB's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Return-on-Tangible-Asset is -9.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 51.8% below its estimated GF Value™ of kr266.73.
Key valuation signals for CHIX:BACTBS:
Return-on-Tangible-Asset: -9.15%
GF Value™: kr266.73 vs. price of kr128.60 (51.8% below fair value)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
56GF Score
Get the complete analysis for CHIX:BACTBS
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
